TickerFacts.

MapLight Therapeutics, Inc. (MPLT): Shareholders' Equity

Annual figures by period end, from SEC filings.

$458.37M
As of 2025-12-31
$348.30M
As of 2026-06-30
2024-12-31: -$193.63M2025-12-31: $458.37M$458.37M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$458.37Mn/m2026-03-26, Balance as of period end
2024-12-31-$193.63Mn/a2026-03-26, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
MapLight Therapeutics, Inc. (MPLT)2025-12-31$458.37Mn/m
Rhythm Pharmaceuticals, Inc. (RYTM)2025-12-31$139.07M+540.0%
Enliven Therapeutics, Inc. (ELVN)2025-12-31$459.60M+48.3%
Oruka Therapeutics, Inc. (ORKA)2025-12-31$471.93M+23.5%
Vanda Pharmaceuticals Inc. (VNDA)2025-12-31$327.19M-39.2%
Ardelyx, Inc. (ARDX)2025-12-31$166.95M-3.7%
Biohaven Ltd. (BHVN)2025-12-31$52.07M-87.7%
Rapport Therapeutics, Inc. (RAPP)2025-12-31$484.65M+58.7%
BridgeBio Oncology Therapeutics, Inc. (BBOT)2025-12-31$411.10Mn/m

Compare MPLT, RYTM, ELVN, ORKA side by side · Screen every company in Pharmaceutical Preparations ↗